Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Bluebird, Moderna, Navitor, & More 06/20/14 Boston
As Its Investors Reap Returns, venBio Aims for a Bigger Second Fund 06/10/14 San Francisco
Akebia, Trading M&A For an IPO, Follows Fast in Anemia Drug Race 06/09/14 Boston
East Coast Biotech Roundup: Berg, Forma/Celgene, Intarcia, & More 04/04/14 Boston
Alder BioPharmaceuticals Hits IPO Trail Looking for $115M 03/19/14 Seattle
Elliott Sigal, Bristol’s Former R&D Chief, on Life After Big Pharma 02/25/14 New York
East Coast Biotech Roundup: Genocea, Eleven, NIH/Pharma, & More 02/07/14 Boston
The $1K Genome? So What? Illumina Is On a Quest for World Domination 02/03/14 National
Social Media & Cancer Drugs: Conversation, not Promotion 01/23/14 Wisconsin
Alkermes Nabs $250M It Doesn’t Need, But Could Fend Off Barbarians 01/13/14 Boston
Zymeworks Nabs $15M, Adds Lilly Partnership, in Antibody Drug Quest 01/09/14 Seattle
Bad Statistics, and Bad Training, Are Sabotaging Drug Discovery 01/06/14 Seattle
Scientific Reproducibility: Raising the Standards for Biomedicine 01/03/14 National
Remembering James L. Vincent, Longtime Biogen Leader 12/31/13 Boston
Atara Bio Grabs $38.5M to Help Kidney Patients, Fight Cancer 12/17/13 San Francisco
Modern Day Scrooges Are Ruining Our Health Care System 12/03/13 Seattle
3 Life Sciences Companies That Are Built to Last 12/02/13 National
How Alkermes Survived a Brush With Death 11/11/13 National
Immunogen Halts Study as Cancer Drug Flops, Shares Fall 11/05/13 Boston
The Biggest Bargains Pharma Scooped Up in the Down Years 10/28/13 National
East Coast Biotech Roundup: Pronutria, Alzheon, Nextcode, & More 10/25/13 Boston
DeCode Spinout, NextCode Health, Launches With $15M From Arch, Polaris 10/23/13 Boston
21 Red Flags to Watch for in a Biotech Company 10/21/13 National
Regeneron, Sanofi Pass First Key Test With Cholesterol-Lowering Drug 10/16/13 New York
The Human Genome Project Wasn’t Overhyped. The Payoff Just Took Time 10/03/13 National
Biotech CEOs Don’t Know It All. They Need Mentors 09/26/13 San Diego
The Best Biotech Graduate Schools in Real Life 09/23/13 National
Langer’s Bind Therapeutics Prices IPO at $15 Per Share 09/20/13 Boston
Disappointments, New Prospects for Rigel Pharmaceuticals 09/10/13 San Francisco
Are Some Degrees Better than Others for Big Pharma Leaders? 09/09/13 Seattle
Page 2 of 13 « previous page · next page »